APLNR and Parkinson disease: Apelin-13 is an endogenous ligand for APJ [115] that has been investigated as a potential protective neuropeptide due to the role of the apelin-APJ system in neuronal survival [116], while allopregnanolone is a reduced metabolite of progesterone [117] and has reduced CSF levels in PD patients [118].